Home IPO-bound Aduro snags Big Pharma cancer immunotherapy deal
 

Keywords :   


IPO-bound Aduro snags Big Pharma cancer immunotherapy deal

2015-03-30 11:22:11| Biotech - Topix.net

Tiny Aduro Biotech Inc. hopes to put the STING on cancer with a potential $750 million deal between the Berkeley company and drug giant Novartis AG. The deal centers on experimental synthetic small molecules, developed by Aduro, that could be the latest weapon in the hot field of cancer immunotherapy.

Tags: big deal cancer pharma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.05Dine and dash couple hit my pizzeria, says owner
15.05Boeing may face criminal prosecution, US says
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
More »